XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in- Capital
Accumulated Deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2023   43,257,862      
Beginning balance at Dec. 31, 2023 $ 179,672 $ 42 $ 995,464 $ (816,026) $ 192
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 105,581 105,581      
Issuance of common stock upon exercise of stock options $ 206   206    
Issuance of restricted stock awards (in shares)   533,601      
Issuance of restricted stock awards 1 $ 1      
Proceeds from at-the-market offering, net of commissions and fees and issuance costs (in shares)   6,045,428      
Proceeds from at-the-market offering, net of commissions and fees and issuance costs 56,216 $ 2 56,214    
Issuance of common stock in connection with Velodyne Merger (in shares)   211,216      
Issuance of common stock upon vesting of restricted stock units (in shares)   2,022,741      
Issuance of common stock upon vesting of restricted stock units 2 $ 2      
Issuance of common stock to employees under employee stock purchase plan (in shares)   384,341      
Issuance of common stock to employees under employee stock purchase plan 1,703   1,703    
Common stock warrants issuable to customer 892   892    
Stock-based compensation expense 40,459   40,459    
Net loss (97,045)     (97,045)  
Other comprehensive (loss) income $ (1,195)       (1,195)
Ending balance (in shares) at Dec. 31, 2024 52,560,770 52,560,770      
Ending balance at Dec. 31, 2024 $ 180,911 $ 47 1,094,938 (913,071) (1,003)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 43,904 43,904      
Issuance of common stock upon exercise of stock options $ 83 $ 0 83    
Forfeited restricted stock awards (in shares)   (68,072)      
Proceeds from at-the-market offering, net of commissions and fees and issuance costs (in shares)   4,671,406      
Proceeds from at-the-market offering, net of commissions and fees and issuance costs 95,158 $ 1 95,157    
Issuance of common stock in connection with Velodyne Merger (in shares)   205,642      
Issuance of common stock in connection with Velodyne Merger 0   0    
Issuance of common stock upon vesting of restricted stock units (in shares)   3,139,352      
Issuance of common stock upon vesting of restricted stock units 0 $ 0 0    
Issuance of common stock to employees under employee stock purchase plan (in shares)   394,755      
Issuance of common stock to employees under employee stock purchase plan 1,955   1,955    
Common stock warrants issuable to customer 2,623   2,623    
Stock-based compensation expense 40,824   40,824    
Net loss (60,377)     (60,377)  
Other comprehensive (loss) income $ 561       561
Ending balance (in shares) at Dec. 31, 2025 60,947,757 60,947,757      
Ending balance at Dec. 31, 2025 $ 261,738 $ 48 $ 1,235,580 $ (973,448) $ (442)